Benign Recurrent Intrahepatic Cholestasis Type 2 in Siblings with Novel ABCB11 Mutations
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Benign recurrent intrahepatic cholestasis (BRIC), a rare cause of cholestasis, is characterized by recurrent episodes of cholestasis without permanent liver damage. BRIC type 2 (BRIC2) is an autosomal recessive disorder caused by ABCB11 mutations. A 6-year-old girl had recurrent episodes of jaundice. At two months of age, jaundice and hepatosplenomegaly developed. Liver function tests showed cholestatic hepatitis. A liver biopsy revealed diffuse giant cell transformation, bile duct paucity, intracytoplasmic cholestasis, and periportal fibrosis. An ABCB11 gene study revealed novel compound heterozygous mutations, including c.2075+3A>G in IVS17 and p.R1221K. Liver function test results were normal at 12 months of age. At six years of age, steatorrhea, jaundice, and pruritus developed. Liver function tests improved following administration of phenylbutyrate and rifampicin. Her younger brother developed jaundice at two months of age and his genetic tests revealed the same mutations as his sister. This is the first report of BRIC2 confirmed by ABCB11 mutations in Korean siblings.
Abstract
Benign recurrent intrahepatic cholestasis (BRIC), a rare cause of cholestasis, is characterized by recurrent episodes of cholestasis without permanent liver damage. BRIC type 2 (BRIC2) is an autosomal recessive disorder caused by ABCB11 mutations. A 6-year-old girl had recurrent episodes of jaundice. At two months of age, jaundice and hepatosplenomegaly developed. Liver function tests showed cholestatic hepatitis. A liver biopsy revealed diffuse giant cell transformation, bile duct paucity, intracytoplasmic cholestasis, and periportal fibrosis. An ABCB11 gene study revealed novel compound heterozygous mutations, including c.2075+3A>G in IVS17 and p.R1221K. Liver function test results were normal at 12 months of age. At six years of age, steatorrhea, jaundice, and pruritus developed. Liver function tests improved following administration of phenylbutyrate and rifampicin. Her younger brother developed jaundice at two months of age and his genetic tests revealed the same mutations as his sister. This is the first report of BRIC2 confirmed by ABCB11 mutations in Korean siblings.
참고문헌 (20)
- Chawla N, "Benign recurrent intrahepatic cholestasis (BRIC) – a case report and review of literature", Internet J Pathol, 9 (2008)
- Geethalakshmi S, "Benign recurrent intrahepatic cholestasis : a rare case report", Int J Sci Study, 2, pp.222~224 (2014)
- van Mil SW, "Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11", Gastroenterology, 127, pp.379~384 (2004)
- Kagawa T, "Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells", Am J Physiol Gastrointest Liver Physiol, 294, pp.G58~67 (2008)
- Adzhubei I, "Predicting functional effect of human missense mutations using PolyPhen-2. Current protocols in human genetics" (2013), John Wiley & Sons, Inc
- Schwarz JM, "MutationTaster evaluates disease-causing potential of sequence alterations", Nat Methods, 7, pp.575~576 (2010)
- Summerskill WH, "Benign recurrent intrahepatic"obstructive"jaundice", Lancet, 2, pp.686~690 (1959)
- Luketic VA, "Benign recurrent intrahepatic cholestasis", Clin Liver Dis, 8, pp.133~149 (2004)
- van der Woerd WL, "Familial cholestasis : progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy", Best Pract Res Clin Gastroenterol, 24, pp.541~553 (2010)
- Strautnieks SS, "Severe bile salt export pump deficiency : 82 different ABCB11 mutations in 109 families", Gastroenterology, 134, pp.1203~1214 (2008)
- Keitel V, "Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis", Hepatology, 41, pp.1160~1172 (2005)
- Noe J, "Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis", J Hepatol, 43, pp.536~543 (2005)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- Knisely AS, "Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency", Hepatology, 44, pp.478~486 (2006)
- Hayashi H, "4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps", Hepatology, 45, pp.1506~1516 (2007)
- Balsells F, "Benign recurrent intrahepatic cholestasis: improvement of pruritus and shortening of the symptomatic phase with rifampin therapy: a case report", Clin Pediatr (Phila), 36, pp.483~485 (1997)
- 이수정, "Early Diagnosis of ABCB11 Spectrum Liver Disorders by Next Generation Sequencing", Pediatric Gastroenterology, Hepatology & Nutrition, 20(2), pp.114~123 (2017), 대한소아소화기영양학회
- Misawa T, "Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2", Bioorg Med Chem, 20, pp.2940~2949 (2012)
- van der Woerd WL, "Current and future therapies for inherited cholestatic liver diseases", World J Gastroenterol, 23, pp.763~775 (2017)
- Gonzales E, "Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2 : evidence for improvement of cholestasis with 4-phenylbutyrate", Hepatology, 62, pp.558~566 (2015)